vs
Laird Superfood, Inc.（LSF）与Silence Therapeutics plc（SLN）财务数据对比。点击上方公司名可切换其他公司
Silence Therapeutics plc的季度营收约是Laird Superfood, Inc.的1.2倍（$15.7M vs $13.3M），Laird Superfood, Inc.净利率更高（-13.2% vs -14.7%，领先1.6%）
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
Silence Therapeutics是一家总部位于英国伦敦的制药企业，成立于1994年。该企业率先开展小干扰核糖核酸（siRNA）疗法的研发工作，主打罕见病治疗领域，目前在伦敦（总部设于伦敦哈默史密斯）、新泽西和柏林均设有办公点。
LSF vs SLN — 直观对比
营收规模更大
SLN
是对方的1.2倍
$13.3M
净利率更高
LSF
高出1.6%
-14.7%
损益表 — Q4 FY2025 vs Q1 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $13.3M | $15.7M |
| 净利润 | $-1.8M | $-2.3M |
| 毛利率 | 34.1% | 82.2% |
| 营业利润率 | -13.5% | -35.6% |
| 净利率 | -13.2% | -14.7% |
| 营收同比 | 15.0% | — |
| 净利润同比 | -341.4% | — |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSFSLN
| Q4 25 | $13.3M | — | ||
| Q3 25 | $12.9M | — | ||
| Q2 25 | $12.0M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $11.8M | — | ||
| Q2 24 | $10.0M | — | ||
| Q1 24 | $9.9M | $15.7M |
净利润LSFSLN
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-975.1K | — | ||
| Q2 25 | $-362.2K | — | ||
| Q1 25 | $-156.2K | — | ||
| Q4 24 | $-398.4K | — | ||
| Q3 24 | $-166.1K | — | ||
| Q2 24 | $-239.1K | — | ||
| Q1 24 | $-1.0M | $-2.3M |
毛利率LSFSLN
| Q4 25 | 34.1% | — | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 41.9% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 40.0% | 82.2% |
营业利润率LSFSLN
| Q4 25 | -13.5% | — | ||
| Q3 25 | -7.7% | — | ||
| Q2 25 | -3.3% | — | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | -4.1% | — | ||
| Q3 24 | -2.3% | — | ||
| Q2 24 | -3.4% | — | ||
| Q1 24 | -11.0% | -35.6% |
净利率LSFSLN
| Q4 25 | -13.2% | — | ||
| Q3 25 | -7.6% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -1.3% | — | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | -1.4% | — | ||
| Q2 24 | -2.4% | — | ||
| Q1 24 | -10.3% | -14.7% |
每股收益（稀释后）LSFSLN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $11.5M | $156.8M |
| 总资产 | $19.2M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LSFSLN
| Q4 25 | $5.1M | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $8.3M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $7.1M | — |
股东权益LSFSLN
| Q4 25 | $11.5M | — | ||
| Q3 25 | $12.8M | — | ||
| Q2 25 | $13.4M | — | ||
| Q1 25 | $13.3M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $12.6M | — | ||
| Q1 24 | $12.7M | $156.8M |
总资产LSFSLN
| Q4 25 | $19.2M | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | $21.5M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $18.8M | — | ||
| Q2 24 | $18.0M | — | ||
| Q1 24 | $17.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $68.4K | $-9.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LSFSLN
| Q4 25 | $68.4K | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $-2.8M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $339.2K | — | ||
| Q3 24 | $305.8K | — | ||
| Q2 24 | $642.7K | — | ||
| Q1 24 | $-422.3K | $-9.1M |
资本支出强度LSFSLN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
SLN
暂无分部数据
